Indeed, The Cancer Genome Atlas database (https://www.proteinatlas.org/) suggests that low TMEM206 expression weakly correlates with decreased survival of patients with pancreatic cancer that displays a high prevalence of KRAS mutations46. This evidence concerns the gene PACC1 and pancreatic neoplasm.